MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy

Clinical trial NCT01851252 · COMPLETED

Trial details

NCT number: NCT01851252
Sponsor: Meridian Bioscience, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Liver Disease Cirrhosis Esophageal Varices Portal Hypertension Bleeding

Start date: 2013-10-01
Primary completion: 2017-08-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.